Suppr超能文献

一项针对接受静脉-静脉体外膜肺氧合治疗的患者评估非滴定、基于体重的抗凝方案的初步研究。

Pilot study evaluating a non-titrating, weight-based anticoagulation scheme for patients on veno-venous extracorporeal membrane oxygenation.

作者信息

Deatrick Kristopher B, Galvagno Samuel M, Mazzeffi Michael A, Kaczoroswki David J, Herr Daniel L, Rector Raymond, Hochberg Eric, Rabinowitz Ronald P, Scalea Thomas M, Menaker Jay

机构信息

Department of Surgery, School of Medicine, University of Maryland, Baltimore, MD, USA.

Department of Anesthesia, School of Medicine, University of Maryland, Baltimore, MD, USA.

出版信息

Perfusion. 2020 Jan;35(1):13-18. doi: 10.1177/0267659119850024. Epub 2019 May 23.

Abstract

OBJECTIVE

There is no universally accepted algorithm for anticoagulation in patients on veno-venous extracorporeal membrane oxygenation. The purpose of this pilot study was to compare a non-titrating weight-based heparin infusion to that of a standard titration algorithm.

METHODS

We performed a prospective randomized non-blinded study of patients: Arm 1-standard practice of titrating heparin to activated partial thromboplastin times goal of 45-55 seconds, and Arm 2-a non-titrating weight-based (10 units/kg/h) infusion. Primary outcome was need for oxygenator/circuit changes. Secondary outcomes included differences in hemolysis and bleeding episodes. Descriptive statistics were performed for the continuous data, and primary and secondary outcomes were compared using Fisher's exact test as appropriate.

RESULTS

Six patients were randomized to Arm 1 and four to Arm 2. There was no difference in age, pH, PO/FO ratio, peak inspiratory pressure, positive end expiratory pressure, mean airway pressure at time of cannulation, time on extracorporeal membrane oxygenation, or survival to hospital discharge in the two arms. Arm 1 had a statistically higher median activated partial thromboplastin times (48 (43, 52) vs 38 (35, 42), p < 0.008) and lower LDH (808 units/L (727, 1112) vs 940 units/L (809, 1137), p = 0.02) than Arm 2. There was no difference in plasma hemoglobin (4.3 (2.5, 8.7) vs 4.3 (3.0, 7.3), p = 0.65) between the two arms. There was no difference in mean oxygenator/circuit change, transfused packed red blood cell, or documented bleeding complications per patient in each arm (p = 0.56, 0.43, 0.77, respectively).

CONCLUSION

In this pilot study, a non-titrating, weight-based heparin infusion appears safe and as effective in preventing veno-venous extracorporeal membrane oxygenation circuit thrombotic complications as compared to a titration algorithm. Larger studies are needed to confirm these preliminary findings.

摘要

目的

对于接受静脉 - 静脉体外膜肺氧合治疗的患者,目前尚无普遍接受的抗凝方案。本初步研究的目的是比较基于体重的非滴定式肝素输注与标准滴定算法。

方法

我们对患者进行了一项前瞻性随机非盲研究:第1组 - 将肝素滴定至活化部分凝血活酶时间目标为45 - 55秒的标准做法,第2组 - 基于体重的非滴定式(10单位/千克/小时)输注。主要结局是是否需要更换氧合器/回路。次要结局包括溶血和出血事件的差异。对连续数据进行描述性统计,并根据情况使用Fisher精确检验比较主要和次要结局。

结果

6例患者被随机分配至第1组,4例至第2组。两组在年龄、pH值、氧分压/吸氧分数比、吸气峰压、呼气末正压、插管时平均气道压、体外膜肺氧合时间或出院生存率方面无差异。第1组活化部分凝血活酶时间中位数在统计学上高于第2组(48(43,52)对38(35,42),p < 0.008),而乳酸脱氢酶低于第2组(808单位/升(727,1112)对940单位/升(809,1137),p = 0.02)。两组之间血浆血红蛋白无差异(4.3(2.5,8.7)对4.3(3.0,7.3),p = 0.65)。每组中每位患者的平均氧合器/回路更换次数、输注的浓缩红细胞或记录的出血并发症无差异(分别为p = 0.56、0.43、0.77)。

结论

在本初步研究中,与滴定算法相比,基于体重的非滴定式肝素输注在预防静脉 - 静脉体外膜肺氧合回路血栓形成并发症方面似乎安全且有效。需要更大规模的研究来证实这些初步发现。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验